Atlas FDA

RADIESSE INJECTABLE IMPLANT

FDA premarket approval P050052/S020 · decided 2009-02-25

Approval details

PMA number
P050052
Supplement
S020
Supplement type
Real-Time Process
Supplement reason
Labeling Change - Indications/instructions/shelf life/tradename
Trade name
RADIESSE INJECTABLE IMPLANT
Generic name
Implant, dermal, for aesthetic use
Applicant
Merz North America, Inc.
Date received
2009-01-29
Decision date
2009-02-25
Days to decision
27 days
Decision code
APPR
Product code
LMH
Advisory committee
General, Plastic Surgery
Expedited review
No
Location
Franksville, WI
Statement
APPROVAL FOR THE ADDITION OF A 0.8 CC FILL VOLUME INJECTABLE IMPLANT AND ASSOCIATED LABELING CHANGES.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
DESCRIBE PFD Patch (K172689)Merz North America, Inc.2017-11-29